Insider Cluster (2 insiders) ·Filed Sep 3, 2026

ONC

BeOne Medicines Ltd.
NEUTRAL
Impact 2/10
Horizondays Processed28d 11h ago
Insider cluster: 2 insiders, $153K total
Actionable Insight • Neutral

No actionable signal. The dollar amount is noise for a $41B company. Monitor the next 10-Q for any change in the fundamental narrative — this cluster is not predictive.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+5d
ONC ▼ -4.46% at T+5d
NEUTRAL call ✗ call lost -4.46% · α vs SPY -3.31% · entry $362.68 → $346.51
Next anchor: T+20d due yesterday
Latest observation: T+17 -3.99% FF3 residual α
Entry anchored
Sep 2, 04:00 PM ET
via 1-min bar
T+1d
-1.22%
call -1.22% · α -0.83%
$358.26
settled 29d ago
T+5d
-4.46%
call -4.46% · α -3.31%
$346.51
settled 22d ago
T+20d
—
call — · α —
—
due yesterday
T+60d
—
call — · α —
—
in 8w

Price Chart

Loading chart...

Executive Summary

Two ONC insiders (PAO Ball and COO Wu) sold a combined $153K in open-market transactions over a one-week window. The cluster value is ~0.0004% of the $41.1B market cap, well below any materiality threshold. The sales follow the company's H1 2026 STAR Market dual-listing update (filed 9 days earlier), but the minuscule amounts relative to market cap and the executives' typical holdings indicate routine diversification, not a bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$153.0K
Insiders
2

Key Facts

  • Principal Accounting Officer Ball sold 132 shares ($47K) on Sep 1, 2026 at $355.86.
  • President & COO Wu sold 280 shares ($106K) on Aug 25, 2026 at $380.00.
  • Total cluster value of $153K represents ~0.0004% of ONC's $41.1B market cap.
  • Cluster follows the Aug 26, 2026 STAR Market dual-listing disclosure (neutral, impact 2).
  • Prior reports on ONC have a 60% win rate T+20 and avg alpha +3.00%.
  • The SCORE CALIBRATION block shows p_obs=42% at score=6, and p_obs=42% at score=7, which would argue against an inflated score for a bullish read — but the cluster is too small to warrant a bullish read anyway.

Financial Impact

$153K of insider selling vs $41.1B market cap (<0.001%)

Risk Factors

  • Insider sales could accelerate if the stock continues rising, but current pace is unremarkable.

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
92% bullish (12 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ONC-1788506408130
19 reports for ONC
Performance horizon
60% Hit rate 3 of 5 directional calls best @ T+20▲ +10.46%Aug 5, 2026
Filters
Rows
Reports for ONC — sortable, filterable
TypeNow
Sep 10, 2026
21d ago
Insider Cluster
NEUTRAL ★ 3/10
$346.51 $350.84▲ +1.25%▲ +1.47%$352.97 (+1.86%)
Sep 3, 2026
29d ago
Insider Cluster
NEUTRAL ★ 2/10
$362.68 $346.51▼ −4.46%▼ −3.31%$352.97 (−2.68%)
Aug 26, 2026
5w ago
8-K
NEUTRAL ★ 2/10
$375.80 $361.78▼ −3.73%▼ −3.61%$352.97 (−6.08%)
Aug 14, 2026
7w ago
Insider Cluster
NEUTRAL ★ 4/10
$347.48 $374.47▲ +7.77%▲ +9.14%$352.97 (+1.58%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 4/10
$356.01 $369.16▲ +3.69%▲ +5.66%$352.97 (−0.85%)
Aug 10, 2026
7w ago
144
BEARISH ★ 6/10
$359.27 $369.15▼ −2.75%▼ −3.15%$352.97 (+1.75%)
Aug 5, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$329.80 $356.01▲ +7.95%▲ +6.73%$352.97 (+7.03%)
Aug 5, 2026
8w ago
8-K
BULLISH ★ 7/10
$327.53 $359.05▲ +9.62%▲ +9.27%$352.97 (+7.77%)
Jul 24, 2026
10w ago
Insider Cluster
NEUTRAL ★ 2/10
$325.90 $322.08▼ −1.17%▼ −1.55%$352.97 (+8.31%)
Jul 17, 2026
11w ago
Insider Cluster
BEARISH ★ 5/10
$312.02 $326.77▼ −4.73%▼ −5.41%$352.97 (−13.12%)
Showing 10 of 19

US Market Status

Market Open — Closes in 1h 24m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Sep 4, 2026